Rchr
J-GLOBAL ID：201601002314959414
Update date: Mar. 27, 2026
yonehiro kanemura
カネムラ ヨネヒロ | yonehiro kanemura
Affiliation and department：
Research field (3)：
Neurosurgery
, Neuropathology
, Genetics
Papers (136)：
-
Takahiro Sanada, Takeshi Shimizu, Yoshiko Okita, Hideyuki Arita, Hirotaka Sato, Masato Saito, Nobuyuki Mitsui, Satoru Hiroshima, Kayako Isohashi, Mishie Tanino, et al. Radiomics Analysis of Non-Enhancing Lesions After Bevacizumab Administration in Recurrent Glioblastoma. Bioengineering. 2025. 13. 1. 28-28
-
Hideyuki Arita, Kentaro Hirai, Mio Sakai, Tatsuya Hagioka, Koji Takano, Toru Umehara, Hidenori Yoshizawa, Yoshinori Kodama, Nobuo Kashiwagi, Katsuyuki Nakanishi, et al. Gyriform infiltration indicates tumor invasion burden of isocitrate dehydrogenase 1/2-wildtype gliomas. Brain tumor pathology. 2025
-
Hirokazu Nakatogawa, Junya Fukai, Hiroshi Kawaji, Nobuhide Hayashi, Ema Yoshioka, Yoshinori Kodama, Kosuke Nakajo, Takehiro Uda, Yoshiki Arakawa, Shigeki Takada, et al. Characteristics and outcomes of diffuse non-midline gliomas with H3F3A gene mutation in the Kansai Molecular Diagnosis Network for CNS Tumors (Kansai Network): multicenter retrospective cohort study. Acta neuropathologica communications. 2025. 13. 1. 77-77
-
Takahiro Sanada, Shota Yamamoto, Mio Sakai, Toru Umehara, Hirotaka Sato, Masato Saito, Nobuyuki Mitsui, Satoru Hiroshima, Ryogo Anei, Yonehiro Kanemura, et al. Correlation of T1- to T2-weighted signal intensity ratio with T1- and T2-relaxation time and IDH mutation status in glioma. Scientific Reports. 2022. 12. 1. 18801-18801
-
里見 介史, 藤本 健二, 有田 英之, 山崎 夏維, 松下 裕子, 中村 大志, 宮北 康二, 梅原 徹, 小林 啓一, 田村 郁, et al. IDH野生型びまん性星細胞腫は存在するか?. 日本病理学会会誌. 2022. 111. 1. 236-236
ｍore...
MISC (170)：
-
Noriyuki Kijima, Daisuke Kanematsu, Tomoko Shofuda, Ema Yoshioka, Atsuyo Yamamoto, Yukako Handa, Hayato Fukusumi, Asako Katsuma, Shusuke Moriuchi, Masahiro Nonaka, et al. GENETIC AND MOLECULAR PROPERTIES OF LONG-TERM PROLIFERATING TUMORSPHERE -FORMING GLIOMA DERIVED CELLS. NEURO-ONCOLOGY. 2021. 23. 216-216
-
Noriyuki Kijima, Yoshikazu Nakajima, Daisuke Kanematsu, Tomoko Shofuda, Yuichiro Higuchi, Hiroshi Suemizu, Kanji Mori, Yoshinori Kodama, Masayuki Mano, Atsushi Sasaki, et al. ESTABLISHMENT OF PATIENT-DERIVED XENOGRAFTS FROM RARE PRIMARY BRAIN TUMORS. NEURO-ONCOLOGY. 2020. 22. 234-234
-
Noriyuki Kijima, Daisuke Kanematsu, Tomoko Shofuda, Masahiro Nonaka, Ryoichi Iwata, Junya Fukai, Akihiro Inoue, Takashi Sasayama, Naohiro Tsuyuguchi, Toshiyuki Kawashima, et al. CHARACTERIZATION OF PATIENT-DERIVED PRIMARY CELL LINES AND XENOGRAFTS FOR GLIOBLASTOMA. NEURO-ONCOLOGY. 2019. 21. 262-262
-
Kanji Mori, Tomoko Shofuda, Yoshiko Okita, Hideyuki Arita, Manabu Kinoshita, Yuzo Terakawa, Naohiro Tsuyuguchi, Yusuke Tomogane, Junya Fukai, Kenichi Ishibashi, et al. GLIOBLASTOMA TREATMENT OF BEVACIZUMAB ERA IN KANSAI REGION, JAPAN. NEURO-ONCOLOGY. 2017. 19. 68-69
-
Noriyuki Kijima, Yonehiro Kanemura. Different intellectual outcomes in molecular subgroups of medulloblastoma. TRANSLATIONAL CANCER RESEARCH. 2016. 5. S1311-S1314
ｍore...
Patents (26)：
Books (1)：
-
再生医療とリハビリテーション
三輪書店 2018 ISBN:4895906280
Lectures and oral presentations (18)：
-
大阪医療センター 臨床研究センター セルプロセッシングセンターの管理と運用について
(国立病院総合医学会講演抄録集 2024)
-
WHO新分類(WHO2021)の課題とその克服2:脳腫瘍病理形態診断と分子診断の融合の可能性 ヒストンH3 K27M変異グリオーマの臨床・病理学的解析 ミッドライン症例とノンミッドライン症例の比較検討
(Brain Tumor Pathology 2024)
-
特徴的な分子遺伝学的異常を認めたLarge cell/Anaplastic Medulloblastomaの2症例
(Brain Tumor Pathology 2022)
-
in vitro 創薬・毒性試験に使用可能なヒトiPS 細胞由来神経系細胞の開発
(日本薬理学会第138年会 2018)
-
ヒトiPS細胞由来神経前駆細胞における残留iPS細胞の高感度検出法の開発
(第17回日本再生医療学会総会 2018)
ｍore...
Return to Previous Page
